ATE98120T1 - Verwendung von metformin zur herstellung von arzneimitteln. - Google Patents

Verwendung von metformin zur herstellung von arzneimitteln.

Info

Publication number
ATE98120T1
ATE98120T1 AT88400484T AT88400484T ATE98120T1 AT E98120 T1 ATE98120 T1 AT E98120T1 AT 88400484 T AT88400484 T AT 88400484T AT 88400484 T AT88400484 T AT 88400484T AT E98120 T1 ATE98120 T1 AT E98120T1
Authority
AT
Austria
Prior art keywords
metformin
pharmaceuticals
manufacture
preparation
medicaments
Prior art date
Application number
AT88400484T
Other languages
English (en)
Inventor
Nicolas Wiernsperger
Marcel Grand
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Application granted granted Critical
Publication of ATE98120T1 publication Critical patent/ATE98120T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88400484T 1987-03-06 1988-03-02 Verwendung von metformin zur herstellung von arzneimitteln. ATE98120T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8703028A FR2611500B1 (fr) 1987-03-06 1987-03-06 Emploi de derives du biguanide dans la preparation de medicaments
EP88400484A EP0283369B1 (de) 1987-03-06 1988-03-02 Verwendung von Metformin zur Herstellung von Arzneimitteln

Publications (1)

Publication Number Publication Date
ATE98120T1 true ATE98120T1 (de) 1993-12-15

Family

ID=9348653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88400484T ATE98120T1 (de) 1987-03-06 1988-03-02 Verwendung von metformin zur herstellung von arzneimitteln.

Country Status (10)

Country Link
EP (1) EP0283369B1 (de)
JP (1) JPH0818978B2 (de)
AT (1) ATE98120T1 (de)
AU (1) AU610134B2 (de)
CA (1) CA1328606C (de)
DE (1) DE3886075T2 (de)
DK (1) DK169713B1 (de)
FR (1) FR2611500B1 (de)
IL (1) IL85627A (de)
ZA (1) ZA881540B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100919A (en) * 1984-03-19 1992-03-31 The Rockefeller University Biguanides and derivatives thereof as inhibitors of advanced glycosylation of a target protein
AU651571B2 (en) * 1990-02-09 1994-07-28 Pharmacia & Upjohn Company Use of insulin sensitizing agents to treat hypertension
US5356913A (en) * 1990-02-09 1994-10-18 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
WO1996008262A1 (en) * 1994-09-15 1996-03-21 Pharmagenesis, Inc. Composition and method for immunotherapy
EP1039890B1 (de) * 1997-12-08 2004-03-17 Bristol-Myers Squibb Company Neue metformin salze und verfahren
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
ES2224634T3 (es) * 1998-04-29 2005-03-01 Sumitomo Pharmaceuticals Company, Limited Formulacion oral que comprende biguanida y un acido organico.
JP4606582B2 (ja) * 1998-04-29 2011-01-05 大日本住友製薬株式会社 ビグアナイド系薬物の内服製剤
ATE306910T1 (de) * 1998-07-30 2005-11-15 Merck Sante Sas Tablette mit verlängerter wirkstoffabgabe im magen
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
FR2796551B1 (fr) * 1999-07-23 2003-07-25 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2796940B1 (fr) * 1999-07-26 2005-04-08 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2809310B1 (fr) * 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
AU2001213150A1 (en) * 2000-08-03 2002-02-18 Olga Evgenievna Kolesova Composition of metformin with succinic acid or salts thereof and method for treating diabetes
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
WO2007038979A1 (en) * 2005-09-22 2007-04-12 Swissco Development Ag Effervescent metformin composition and tablets and granules made therefrom
JP4592818B2 (ja) * 2007-01-29 2010-12-08 ハナル バイオファーマ カンパニー リミテッド N,n−ジメチルイミドジカルボンイミド酸ジアミドの酢酸塩、その製造方法、及びそれを含む薬剤学的組成物
GR1007299B (el) * 2010-03-24 2011-06-06 Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2448448A (en) * 1942-06-08 1948-08-31 Courtaulds Ltd Dyeing of textile fibers containing nitrogen

Also Published As

Publication number Publication date
EP0283369B1 (de) 1993-12-08
IL85627A (en) 1993-01-14
DE3886075T2 (de) 1994-04-14
DK169713B1 (da) 1995-01-23
JPH0818978B2 (ja) 1996-02-28
JPS63230628A (ja) 1988-09-27
DK116788A (da) 1988-09-07
CA1328606C (fr) 1994-04-19
AU610134B2 (en) 1991-05-16
EP0283369A2 (de) 1988-09-21
AU1272788A (en) 1988-09-08
IL85627A0 (en) 1988-08-31
FR2611500A1 (fr) 1988-09-09
FR2611500B1 (fr) 1990-05-04
ZA881540B (en) 1988-08-26
DK116788D0 (da) 1988-03-04
EP0283369A3 (en) 1989-11-29
DE3886075D1 (de) 1994-01-20

Similar Documents

Publication Publication Date Title
ATE98120T1 (de) Verwendung von metformin zur herstellung von arzneimitteln.
DE3878866D1 (de) 3-indolpyruvsaeure-derivate und deren verwendung als arznemittel.
DE69033299D1 (de) Verwendung von Carnosolsäure wegen seiner anticarcinogenen und antiviralen Eigenschaften
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE69212620D1 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
DK36889D0 (da) Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af kognitive lidelser
DE3777367D1 (de) Hirudin-variante, deren verwendung und herstellung.
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
ATE76636T1 (de) Verfahren zur herstellung von benzoesaeure und ihren salzen.
DE69214299D1 (de) Verwendung von alkylpolyglycosiden und/oder 0-acylierte glukosederivate zur behandlung des haarausfalls
ATE113939T1 (de) Verfahren zur herstellung von cephalosporin und zwischenverbindungen.
ATE75144T1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
NO890801D0 (no) Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
ATA96787A (de) Verfahren zur herstellung von biuretgruppen enthaltenden selbstvernetzenden kationischen lackbindemitteln und deren verwendung
ATE40888T1 (de) Verfahren zur herstellung von ranitidin oder saeureadditionssalze davon und zwischenprodukte fuer diese herstellung.
DE3688414D1 (de) Verwendung von chinolinderivaten zur herstellung von medikamenten zur behandlung von zerebralen gefaesskrankheiten und zerebraler senilitaet.
ATE95234T1 (de) Verfahren zur herstellung von proteinen mit fviii aktivitaet und/oder fviii derivate.
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DE3586321D1 (de) Verwendung von 1,4-dihydropyridinderivaten.
DE69118847D1 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee